Does LAMOTRIGINE Cause Corneal neovascularisation? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Corneal neovascularisation have been filed in association with LAMOTRIGINE (Lamotrigine ER). This represents 0.0% of all adverse event reports for LAMOTRIGINE.
6
Reports of Corneal neovascularisation with LAMOTRIGINE
0.0%
of all LAMOTRIGINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Corneal neovascularisation From LAMOTRIGINE?
Of the 6 reports, 5 (83.3%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Corneal neovascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMOTRIGINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LAMOTRIGINE Cause?
Drug ineffective (5,175)
Seizure (3,459)
Toxicity to various agents (3,256)
Rash (3,249)
Foetal exposure during pregnancy (2,985)
Off label use (2,625)
Completed suicide (2,433)
Drug reaction with eosinophilia and systemic symptoms (2,235)
Dizziness (2,170)
Pyrexia (1,967)
What Other Drugs Cause Corneal neovascularisation?
BRIMONIDINE (19)
CENEGERMIN-BKBJ (18)
DUPILUMAB (16)
BEVACIZUMAB (11)
CYSTEAMINE (10)
LATANOPROST (8)
TOBRAMYCIN (8)
ADALIMUMAB (7)
FLUOROMETHOLONE (7)
FUSIDIC ACID (7)
Which LAMOTRIGINE Alternatives Have Lower Corneal neovascularisation Risk?
LAMOTRIGINE vs LANADELUMAB
LAMOTRIGINE vs LANADELUMAB-FLYO
LAMOTRIGINE vs LANREOTIDE
LAMOTRIGINE vs LANSOPRAZOLE
LAMOTRIGINE vs LANTHANUM